NORTHEAST FINANCIAL CONSULTANTS INC – BioCryst Pharmaceuticals, Inc. Transaction History

$764,000

portfolio value

+19.09%

quarter

Quarter	Transaction type	Change	Relative change	Absolute change	Change value	Avg. price	Shares
Q3 2022	share		0.00%	0 shares	123K	$12.6	60.63K
Q2 2022	share		0.00%	0 shares	-345K	$10.58	60.63K
Q1 2022	share		0.00%	0 shares	146K	$16.26	60.63K
Q4 2021	share	Increase	+102.11%	30.63K shares	409K	$13.79	60.63K
Q3 2021	share	Increase	+50.00%	10K shares	115K	$14.37	30K
Q2 2021	share		0.00%	0 shares	113K	$15.81	20K
Q1 2021	share	Decrease	-39.68%	-13.15K shares	-44K	$10.17	20K
Q4 2020	share		0.00%	0 shares	133K	$7.45	33.15K
Q3 2020	share	Increase	+65.78%	13.15K shares	19K	$3.44	33.15K
Q2 2020	share		0.00%	0 shares	55K	$4.76	20K
Q1 2020	share		0.00%	0 shares	-29K	$2	20K
Q4 2019	share		0.00%	0 shares	12K	$3.45	20K
Q3 2019	share		0.00%	0 shares	-19K	$2.87	20K
Q2 2019	share		0.00%	0 shares	-87K	$3.79	20K
Q1 2019	share		0.00%	0 shares	2K	$8.14	20K
Q4 2018	share		0.00%	0 shares	9K	$8.07	20K
Q3 2018	share		0.00%	0 shares	38K	$7.63	20K
Q2 2018	share		0.00%	0 shares	19K	$5.73	20K
Q1 2018	share		0.00%	0 shares	-3K	$4.77	20K
Q4 2017	share		0.00%	0 shares	-7K	$4.91	20K
Q3 2017	share		0.00%	0 shares	-6K	$5.24	20K
Q2 2017	share		0.00%	0 shares	-57K	$5.56	20K
Q1 2017	share		0.00%	0 shares	41K	$8.4	20K
Q4 2016	share		0.00%	0 shares	39K	$6.33	20K
Q3 2016	share		0.00%	0 shares	31K	$4.41	20K
Q2 2016	share		0.00%	0 shares	0	$2.84	20K
Q1 2016	share		0.00%	0 shares	-149K	$2.83	20K

NORTHEAST FINANCIAL CONSULTANTS INC portfolio value: